Skip to main content

Table 2 Patient characteristics

From: Immunoprofiling of leukemic stem cells CD34+/CD38−/CD123+ delineate FLT3/ITD-positive clones

Patient characteristics Total (%)
No. of patients 34
Male/female 24/10
Age at diagnosis, mean (range) 63 (23–86)
% blasts at diagnosis (morphology), mean (range) 41.5 (20–96)
% blasts at diagnosis (flow), mean (range) 42.5 (9–86)
WBC count at diagnosis, 109/L, median (range) 4.5 (0.71–179)
De novo/secondary AML 27 (79)/7 (21)
FAB classification, n (%)
 M0 0 (0)
 M1 8 (24)
 M2 10 (29)
 M3 1 (3)
 M4 2 (6)
 M5 4 (12)
 M6 1 (3)
 M7 0 (0)
 Not classified 8 (24)
Cytogenetic risk group, n (%)
 Favorable 2 (6)
 Intermediate 19 (56)
 Poor 12 (35)
 No metaphases 1 (3)
FLT3/ITD, n (%)
 Present 10 (29)
 Absent 15 (44)
 Not analyzed 9 (26)
CD123, n (%)
 Present 32 (94 %)
 Absent 2 (6 %)